CN111606902A - Ester pyrazole bithiazole amine compound and preparation method and application thereof - Google Patents

Ester pyrazole bithiazole amine compound and preparation method and application thereof Download PDF

Info

Publication number
CN111606902A
CN111606902A CN201910141015.2A CN201910141015A CN111606902A CN 111606902 A CN111606902 A CN 111606902A CN 201910141015 A CN201910141015 A CN 201910141015A CN 111606902 A CN111606902 A CN 111606902A
Authority
CN
China
Prior art keywords
compound
saturated
aromatic
benzene ring
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910141015.2A
Other languages
Chinese (zh)
Inventor
叶龙
彭万才
邵辉
唐关平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan University of Science and Engineering WUSE
Wuhan University of Science and Technology WHUST
Original Assignee
Wuhan University of Science and Engineering WUSE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan University of Science and Engineering WUSE filed Critical Wuhan University of Science and Engineering WUSE
Priority to CN201910141015.2A priority Critical patent/CN111606902A/en
Publication of CN111606902A publication Critical patent/CN111606902A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses an ester pyrazole bithiazole amine compound, a preparation method and application thereof, wherein the structural general formula of the compound is as follows:
Figure 296372DEST_PATH_IMAGE001
. The compound is a double five-membered azacyclo bifunctional compound, is convenient for realizing high-flux synthesis and diversified derivation of thiazolylamine and pyrazole, and can be widely applied to research, development and production of thiazole dipyrazole medicaments.

Description

Ester pyrazole bithiazole amine compound and preparation method and application thereof
Technical Field
The invention relates to the technical field of medicinal chemistry, in particular to ester pyrazole isothiazolamine and a preparation method and application thereof.
Background
Thiazole and pyrazole are common compound groups in medicinal chemistry, and the generated derivatives have good biological activity, such as cancer cell migration resistance, antifungal property and anti-proliferation property. The aromatic ring-thiazole-pyrazole organic acid is used as a pharmaceutically active intermediate, and an intermediate with different substituent groups on the aromatic ring needs to be synthesized. The current route for the synthesis of aromatic ring-thiazole-pyrazole organic acids is to perform amide condensation of aromatic (heteroaromatic-containing) acids with different substituents with aminothiazolones, and then perform claisen condensation, pyrazole cyclization and ester hydrolysis reactions, respectively (Long Ye, John M. Knapp, Panjamaporon Sangwung, James C. Fettinger, A.S. Verkman, and Mark J. Kurth, pyrazolythizolyloles. DELTA.F 508-cysteine fibers, transfer membrane reactor Regulator and reactor with improved hydrogenation reaction J. Med. chem. 2010, 53, 3772-3781). In the method, the structural diversification is realized in the early stage of synthesis, and the synthesis of a target product with different substituents is repeated from the synthesis of raw materials, so that the reaction economy is not high. Therefore, the method for efficiently synthesizing the aromatic ring-thiazole-pyrazole organic acid is of great significance to the discovery of medicaments and the research on the structure-activity relationship of compounds and proteins.
Disclosure of Invention
In order to improve the synthesis efficiency of the aromatic ring-thiazole-pyrazole organic acid, according to one aspect of the invention, an ester pyrazole bithiazole amine compound is provided, and the structural general formula of the compound is as follows:
Figure 575259DEST_PATH_IMAGE001
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl groups, aromatic groups (benzene rings and substituted benzene rings).
According to another aspect of the present invention, there is provided a method for preparing the ester pyrazole bithiazole amine compound, the method employs an amino protection strategy, after a pyrazole ring is constructed, the amino group on the thiazole ring is released, so as to facilitate the diversity of the later-stage amino amide condensation reaction, and after the hydrolysis of the ester group on the pyrazole ring, the method can further perform diversity derivatization, and comprises the following steps:
first, compound 1 and (Boc)2Performing amino protection reaction on O (di-tert-butyl dicarbonate) to obtain a compound 2, performing claisen condensation reaction on the compound 2 and diethyl oxalate to obtain a compound 3, performing pyrazole cyclization reaction on the compound 3 and hydrazine hydrate to obtain a compound 4, and performing deprotection reaction on the compound 4 under the action of TFA (trifluoroacetic acid) to obtain a compound 5; the reaction route is as follows:
Figure 654073DEST_PATH_IMAGE002
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl groups, aromatic groups (benzene rings and substituted benzene rings).
According to another aspect of the invention, the application of the ester pyrazole isothiazolamine compound in synthesis of aromatic ring-thiazole-pyrazole organic acid (compound 7) is further provided, namely, the compound 5 is subjected to amide condensation reaction with aromatic (heteroaromatic) acid with different substituents, and then subjected to ester hydrolysis reaction to obtain aromatic ring-thiazole-pyrazole organic acid; the reaction route is as follows:
Figure 214367DEST_PATH_IMAGE003
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, aryl (benzene ring and substituted benzene ring), R7At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, halogen, aromatic base (benzene ring and substituted benzene ring).
Therefore, the invention provides a novel ester pyrazole bithiazole amine compound, and a preparation method and application thereof. The compound is a double five-membered azacyclo bifunctional compound, is convenient for realizing high-flux synthesis and diversified derivation of thiazolylamine and pyrazole, and can be widely applied to research, development and production of thiazole dipyrazole medicaments.
Drawings
FIG. 1 is a drawing of Compound 51H NMR spectrum;
FIG. 2 is a HRMS profile of a bioactive compound.
Detailed Description
The present invention is further illustrated by the following specific examples, which are only intended to illustrate the invention and not to limit the scope of the invention, and all other examples obtained by a person skilled in the art based on the examples of the present invention shall fall within the scope of the protection of the present invention.
Synthesis of the Compound of example 1
The structural formula of the compound is as follows:
Figure 799064DEST_PATH_IMAGE001
wherein in the example compounds R1=CH3,R2=R4=R5=R6=H,R3=Et。
The compounds can be prepared by the following preparation schemes, the reaction schemes are as follows:
Figure 749702DEST_PATH_IMAGE004
the specific synthesis steps are as follows:
(a) preparation of Compound 2
Figure 694524DEST_PATH_IMAGE005
Compound 1 (8.1 g, 51.9 mmol) was added to tetrahydrofuran THF (260 ml) under ice bath, followed by addition of triethylamine (28.86 ml, 207.62 mmol) and 4-dimethylaminopyridine DMAP (95.12 mg, 778.57. mu. mol), respectively, and after 10 min, di-tert-butyl dicarbonate (Boc) was added dropwise2O (71.62 ml, 311.43 mmol), stirring was continued for 10 min, the ice bath was removed and the reaction was heated to reflux for 5 h. Filtering by suction to obtain filtrate, removing solvent to obtain solid, drying, dissolving with DMF, adding water, filtering, and drying to obtain white solid compound 2 (13.3 g, yield 100%).1H NMR (600 MHz,Chloroform-d) 11.31(s,1H),2.69(s,3H),2.50(s,3H),1.56(s,9H)。
(b) Preparation of Compound 3
Figure 47008DEST_PATH_IMAGE006
Dissolving the compound 2 (13.3 g, 51.89 mmol) in dry THF (240 mL), adding the solution into a dry THF solution of lithium bis (trimethylsilyl) amide LHDMS (1M in THF, 92.2 mL) at-50 to-80 ℃, stirring and reacting for 45 min under the protection of nitrogen, adding diethyl oxalate (14.07 mL, 103.78 mmol), and continuing to react for 5 h. Returning to room temperature, rotary evaporation to remove THF, solid grinding into powder, adding water, using 1M HCl to adjust pH to weak acidity, filtering, drying to obtain yellow solid compound 3 (15.5 g yield 83.8%).1H NMR(600 MHz,Methanol-d 4) 4.35(d,J= 8.1 Hz,1H),4.06(s,2H),2.54(s,3H),1.55(s,9H),1.28(s,3H)。
(c) Preparation of Compound 4
Figure 817254DEST_PATH_IMAGE007
Compound 3 (15.5 g, 43.49 mmol) was dissolved in ethanol (217.45 ml), and hydrazine hydrate (2.54 ml, 52.19 mmol) was added thereto, followed by heating under reflux for 8 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, filtered to obtain a filtrate, and the filtrate was evaporated to remove the solvent and dried to obtain compound 4 (14.1 g, yield 93%) as a yellow solid.1H NMR(600 MHz,DMSO-d 6) 11.53 (s,1H),6.92(s,1H),4.32(t,J= 7.1 Hz,2H),2.38(s,3H),1.49 (s,9H),1.32(t,J= 7.0 Hz,3H)。
(d) Preparation of Compound 5
Figure 317506DEST_PATH_IMAGE008
Compound 4 (14.1 g, 40 mmol) was dissolved in dichloromethane DCM (200 ml), and TFA (44.4 ml, 598.1 mmol) was added and reacted at room temperature for 3 h. Removing solvent by rotary evaporation, and adding saturated NaHCO3Then, the reaction mixture was filtered with suction and dried to obtain Compound 5 (7.79 g, yield 78.9%) as a yellow solid.1H NMR(600 MHz,DMSO-d 6) 9.36(s,2H),7.03(s,1H),4.34 – 4.29(m,2H),1.30(t,J= 7.1 Hz,3H)。
EXAMPLE 2 use of Compounds in the Synthesis of aromatic Ring-thiazole-pyrazole organic acids
The structural general formula of the aromatic ring-thiazole-pyrazole organic acid compound is as follows:
Figure 738123DEST_PATH_IMAGE009
in the above formula, R7At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, halogen, aromatic base (benzene ring and substituted benzene ring); the reaction route is as follows:
Figure 23742DEST_PATH_IMAGE010
the specific synthesis steps are as follows:
(a) preparation of Compound 6
Figure 137191DEST_PATH_IMAGE011
Dissolving aromatic acid (1 equiv) with different substituents in DMF, reacting with CDI (1.3 euquiv) for 30min, adding compound 5 (1 equiv), and heating under reflux for 15 h. After the reaction is finished, cooling to room temperature, adding water, filtering to obtain a solid, and drying to obtain the compound 6, wherein the yield is 80%.
When R is7When H, the compound has the structural formula:
Figure 124739DEST_PATH_IMAGE012
1H NMR(600 MHz,Methanol-d 4) 8.02(d,J= 7.7 Hz,2H),7.63(t,J= 7.4 Hz,1H),7.55 (t,J= 7.6 Hz,2H),6.97(s,1H),4.40(q,J= 7.2 Hz,2H),2.48(s,3H),1.40(q,J= 7.0 Hz,3H)。
when R is7Is 4-CH3The structural formula of the compound is as follows:
Figure 162096DEST_PATH_IMAGE013
1H NMR(600 MHz,Methanol-d 4) 7.92(d,J= 7.6 Hz,2H),7.36(t,J= 7.7 Hz,2H),4.40(q,J= 7.3 Hz,2H),2.50(s,3H),2.43(d,J= 6.7 Hz,3H),1.40 (t,J= 7.2Hz,3H)。
when R is7When the structure is 2-Br, the compound formula is as follows:
Figure 223593DEST_PATH_IMAGE014
1H NMR(600 MHz,Methanol-d 4) 7.72(d,J= 8.0 Hz,1H),7.57(d,J= 7.9 Hz,1H),7.50(s,1H),7.45(d,J= 8.3 Hz,1H),6.99(s,1H),4.40(q,J= 7.8, 7.3 Hz,2H),2.48(s,3H),1.41(d,J= 7.8 Hz,3H)。
(b) preparation of Compound 7
Figure 570261DEST_PATH_IMAGE015
Compound 6 (1 equiv) was dissolved in THF, and 1M NaOH (1 equiv) solution was added to react at room temperature for 48 hours. Removing THF by rotary evaporation, extracting to remove impurities, collecting aqueous phase, adding 1M HCl to weak acidity, filtering, and oven drying to obtain compound 7 with yield of 75%.
When R is7When H, the compound has the structural formula:
Figure 982787DEST_PATH_IMAGE016
1H NMR(600 MHz,Methanol-d 4) 8.02(d,J= 7.5 Hz,2H),7.63(t,J= 7.4 Hz,1H),7.55(t,J= 7.3 Hz,2H),6.86(d,J= 5.5 Hz,1H),2.50(s,3H)。
when R is7Is 4-CH3The structural formula of the compound is as follows:
Figure 823836DEST_PATH_IMAGE017
1H NMR(600 MHz,Methanol-d 4) 7.93(s,2H),7.38(s,2H),6.99(s,1H),2.51 s,3H),2.44(s,3H)。
when R is7When the structure is 2-Br, the compound formula is as follows:
Figure 67735DEST_PATH_IMAGE018
1H NMR(600 MHz,Methanol-d 4) 7.73(s,1H),7.48(d,J= 34.1 Hz,2H),7.00(s,1H), 2.51(d,J= 16.5 Hz,3H)。
the above description is only a preferred embodiment of the present invention, and should not be taken as limiting the invention, and all modifications, equivalents, improvements and the like that are included in the spirit and principle of the present invention should be included in the scope of the present invention.

Claims (4)

1. An ester pyrazole bithiazole amine compound has a structural general formula as follows:
Figure 380699DEST_PATH_IMAGE001
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl groups, aromatic groups (benzene rings and substituted benzene rings).
2. The method for preparing an esterpyrazole bithiazole amine compound according to claim 1, which comprises:
first, compound 1 and (Boc)2Performing amino protection reaction on O (di-tert-butyl dicarbonate) to obtain a compound 2, performing claisen condensation reaction on the compound 2 and diethyl oxalate to obtain a compound 3, performing pyrazole cyclization reaction on the compound 3 and hydrazine hydrate to obtain a compound 4, and performing deprotection reaction on the compound 4 under the action of TFA (trifluoroacetic acid) to obtain a compound 5; the reaction route is as follows:
Figure 93571DEST_PATH_IMAGE002
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl groups, aromatic groups (benzene rings and substituted benzene rings).
3. Use of an esterpyrazole bithiazole amine compound as claimed in claim 1 for the synthesis of aromatic ring-thiazole-pyrazole organic acids.
4. Use according to claim 3, wherein the aromatic ring-thiazole-pyrazole organic acid is synthesized by the following route: the compound 5 firstly generates amide condensation reaction with aromatic (containing heteroaromatic) acid with different substituent groups, and then aromatic ring-thiazole-pyrazole organic acid (compound 7) is obtained through ester hydrolysis reaction; the reaction route is as follows:
Figure 721999DEST_PATH_IMAGE003
wherein R is1-R2At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, aromatic radical (benzene ring and substituted benzene ring), R3-R6At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, aryl (benzene ring and substituted benzene ring), R7At least comprising hydrogen and C1-C4Saturated or unsaturated alkyl, saturated or unsaturated alkoxy, halogen, aromatic base (benzene ring and substituted benzene ring).
CN201910141015.2A 2019-02-26 2019-02-26 Ester pyrazole bithiazole amine compound and preparation method and application thereof Pending CN111606902A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910141015.2A CN111606902A (en) 2019-02-26 2019-02-26 Ester pyrazole bithiazole amine compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910141015.2A CN111606902A (en) 2019-02-26 2019-02-26 Ester pyrazole bithiazole amine compound and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN111606902A true CN111606902A (en) 2020-09-01

Family

ID=72202927

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910141015.2A Pending CN111606902A (en) 2019-02-26 2019-02-26 Ester pyrazole bithiazole amine compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111606902A (en)

Similar Documents

Publication Publication Date Title
CN106187882A (en) Prepare method and the synthetic intermediate thereof of compound
CN103649055A (en) Method for manufacturing pyrazole derivative
EP2470182A1 (en) Synthesis of a neurostimulative piperazine
CN113683651A (en) Preparation method of GalNAc intermediate
CN103180308B (en) Novel method of preparing benzoimidazole derivatives
WO2015079018A1 (en) Synthesis of vortioxetine via (2-(piperazine-1 -yl)phenvl)lithium intermediates
JP2018528928A5 (en)
WO2019090269A1 (en) Processes to produce acalabrutinib
CN110790689B (en) Synthetic method of 1, 1-difluoro-2-isonitrile-ethyl phenyl sulfone compound
CN111606902A (en) Ester pyrazole bithiazole amine compound and preparation method and application thereof
CN110511193A (en) A kind of α -one thioamide analog compound and its synthetic method
CN108218804B (en) 4-alkylthio-3-isoxazolone derivative and synthesis method thereof
CN113754605B (en) Nitrogen-containing ligand, and preparation method and application thereof
CN112250682B (en) Aromatic heterocycle modified naphthalimide derivative and preparation method and application thereof
CN109734667B (en) Polysubstituted imidazole compound and synthesis method and application thereof
CN107602454B (en) Sulfonamide compound and preparation method and application thereof
CN106916144B (en) N-alkyl substituted indole-imidazole salt compound and preparation method thereof
CN113121401A (en) N-substituted carbonyl fluorosulfonamide compound, preparation method and application thereof
CN112679457B (en) Process for the preparation of benzamide derivatives and their use
CN104829592B (en) The synthetic method of 4 piperidyl 1H pyrroles, 3 Carbox amide hydrochloride
CN113416162B (en) Double-chiral binaphthyl O-N-N tridentate ligand and preparation method thereof
CN108752316B (en) Tetrahydroisoquinoline-2-methylbenzimidazole salt compound and preparation method and application thereof
JPH061776A (en) Production of substituted pyrazinecarbonitrile
CN111943979B (en) Ifosfamide intermediate, preparation method and application thereof
CN110894186B (en) Preparation method of pimavanserin and intermediate thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200901